Authors:
HEALY DP
DANSEREAU RJ
DUNN AB
CLENDENING CE
MOUNTS AW
DEEPE GS
Citation: Dp. Healy et al., REDUCED TETRACYCLINE BIOAVAILABILITY CAUSED BY MAGNESIUM ALUMINUM SILICATE IN LIQUID FORMULATIONS OF BISMUTH SUBSALICYLATE, The Annals of pharmacotherapy, 31(12), 1997, pp. 1460-1464
Authors:
DANSEREAU RN
DANSEREAU RJ
LINE BR
HEALY D
BEKKER P
Citation: Rn. Dansereau et al., A PHARMACO-SCINTIGRAPHY STUDY OF RIBOFLAVIN 5'-PHOSPHATE SODIUM CAPSULES (1 VS 4), International journal of pharmaceutics, 153(2), 1997, pp. 159-166
Citation: Mh. Brock et al., USE OF IN-VITRO AND IN-VIVO DATA IN THE DESIGN, DEVELOPMENT, AND QUALITY-CONTROL OF SUSTAINED-RELEASE DECONGESTANT DOSAGE FORMS, Pharmacotherapy, 14(4), 1994, pp. 430-437
Citation: Rn. Dansereau et al., LACK OF LEAD CONTAMINATION OF INJECTABLE SOLUTIONS DURING SIMULATED COMPOUNDING AND DISPENSING OF RADIOPHARMACEUTICALS, American journal of hospital pharmacy, 51(14), 1994, pp. 1800-1802